FDA Oncology Announcements

Announcements Trials

Interferon × Dermatologic × Clear all

Conditions

Drug Classes

Anti-PD-1 22 BRAF inhibitor 8 MEK inhibitor 7 Anti-PD-L1 4 Anti-CTLA-4 2 SMO inhibitor 2 TRK inhibitor 2 Anti-HER2 ADC 1 Bispecific gp100 peptide-HLA-directed CD3 T-cell engager 1 Interferon 1 Mononuclear cell vaccine 1 Multi-ingredient 1 Nitrogen mustard 1 Oncolytic viral therapy 1 RET inhibitor 1 ROS1 inhibitor 1

1 Announcement

Peginterferon alfa-2b

Drug: Sylatron (peginterferon alfa-2b) · Interferon
Condition: Dermatologic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡